SCHEDULE 13G/A

Statement of Beneficial Ownership

CytoMed Therapeutics Ltd Filed 2026-10-23 Acc 0001477932-26-006422

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-23 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-10-16 SCHEDULE 13D/A Beneficial Ownership Report
2025-03-24 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)